Insights from 2024 ESMO GI Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2024 ESMO GI Annual Meeting

Videos

Playback speed

10 seconds

ESMO GI 2024 Insights: CodeBreaK 300 - Patient-Reported Tolerability of Sotorasib & Panitumumab vs. Trifluridine/Tipiracil or Regorafenib in mCRC

By Insights from 2024 ESMO GI Annual Meeting FEATURING Julien Taieb

203 views

July 3, 2024

Comments 0

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Hypothetical Patient Case: Hepatocellular Carcinoma and Consideratio…

Feat. J. Gutierrez, J. Strauss

Videos

ESMO GI 2024 Insights: Is It Time For a New Staging System For Colon…

Insights from 2024 ESMO GI Annual Meeting

A. Dasari

128 views

ESMO GI 2024 Insights: Updates on Treatment of Stage II CRC

Insights from 2024 ESMO GI Annual Meeting

E. Martinelli

128 views

ESMO GI 2024 Insights: Ten Years of Improvement in the Treatment of …

Insights from 2024 ESMO GI Annual Meeting

S. L. Chan

137 views

ESMO GI 2024 Insights: DEEPER Trial - m-FOLFOXIRI + Cetuximab vs. Be…

Insights from 2024 ESMO GI Annual Meeting

Y. Sunakawa

131 views

ESMO GI 2024 Insights: Durvalumab + Chemo in Biliary Tract Cancer - …

Insights from 2024 ESMO GI Annual Meeting

D. Oh

87 views

ESMO GI 2024 Insights: Role of Personalized Medicine in Pancreatic C…

Insights from 2024 ESMO GI Annual Meeting

T. Seufferlein

125 views

ESMO GI 2024 Insights: CodeBreaK 300 - Patient-Reported Tolerability…

Insights from 2024 ESMO GI Annual Meeting

J. Taieb

203 views

ESMO GI 2024 Summary: Combined Analysis of ctDNA and Immunoscore in …

Insights from 2024 ESMO GI Annual Meeting

J. Taieb

276 views